Randomized trial meta-analyses report on outcomes in pulmonary arterial hypertension, indicating significant implications for treatment strategies.
Pulmonary arterial hypertension (PAH) is a rare and severe clinical condition characterized by a progressive increase of pulmonary vascular resistance leading to right ventricular failure and premature death (Figure PAH in adults includes at least nine clinical subgroups with virtually identical obstructive pathologic changes (Figures
No takes yet. Share an insight, caveat, or question.
Galiè et al. (2010) studied this question.